BioCentury
ARTICLE | Company News

Millennium, Cytos small molecule deal

December 6, 2001 8:00 AM UTC

MLNM acquired rights from Cytos (Zurich, Switzerland) to screen for small molecules and other drug entities using Cytos' DELphi high throughput functional genomics technology. MLNM also may develop an...